Indian Hydroxychloroquine Exporters: Complete Supplier Ranking with Market Share — 163 Manufacturers (2026) — TransData Nexus

Q: Who is the largest hydroxychloroquine supplier from India?

ZYDUS LIFESCIENCES LIMITED is the largest hydroxychloroquine exporter from India with a 82.5% market share and export value of $116.8M.

Q: How many hydroxychloroquine suppliers are there in India?

There are 163 active hydroxychloroquine exporters in India, collectively shipping $141.5M worth of hydroxychloroquine across 3,717 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top hydroxychloroquine suppliers from India?

The top 5 hydroxychloroquine suppliers from India — ZYDUS LIFESCIENCES LIMITED, IPCA LABORATORIES LIMITED, CADILA HEALTHCARE LIMITED, CADILA HEALTHCARE LTD, INTAS PHARMACEUTICALS LIMITED — together control 96.7% of total hydroxychloroquine export value from India.

Suresh Sormare

Hydroxychloroquine

India Pharmaceutical Trade Intelligence

$141.5M163 Suppliers86 CountriesHS 30049099

ExportsIndia → UNITED STATES89.2%India → UNITED KINGDOM1.9%

ImportsUNITED STATES → India$9.0K THAILAND → India$1.5K

#1 Supplier: ZYDUS LIFESCIENCES #1 Buyer: EVERSANA LIFE

Hydroxychloroquine Suppliers from India (2026) — 163 Exporters, $141.5M Market | TransData Nexus | TransData Nexus

Who Exports Hydroxychloroquine from India — 163 Suppliers Behind a $141.5M Market

India's hydroxychloroquine export market is supplied by 163 active exporters who collectively shipped $141.5M across 3,717 shipments. ZYDUS LIFESCIENCES LIMITED leads with a 82.5% market share, followed by IPCA LABORATORIES LIMITED and CADILA HEALTHCARE LIMITED. The top 5 suppliers together control 96.7% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Hydroxychloroquine Suppliers & Exporters — 163 manufacturers, $141.5M export market, top destinations and formulations — Hydroxychloroquine supplier data — 163 exporters · $141.5M market · 3,717 shipmentsTransData Nexus · Indian Customs Data

Top Hydroxychloroquine Exporters from India — Ranked by Export Value

ZYDUS LIFESCIENCES LIMITED is the leading hydroxychloroquine exporter from India, holding a 82.5% share of the $141.5M market across 3,717 shipments from 163 exporters. The top 5 suppliers — ZYDUS LIFESCIENCES LIMITED, IPCA LABORATORIES LIMITED, CADILA HEALTHCARE LIMITED, CADILA HEALTHCARE LTD, INTAS PHARMACEUTICALS LIMITED — collectively control 96.7% of total export value, indicating a highly concentrated market. Individual shares are: ZYDUS LIFESCIENCES LIMITED (82.5%), IPCA LABORATORIES LIMITED (6.3%), CADILA HEALTHCARE LIMITED (4.7%), CADILA HEALTHCARE LTD (1.9%), INTAS PHARMACEUTICALS LIMITED (1.2%).

Top Hydroxychloroquine Exporters from India

Ranked by export value · 163 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Hydroxychloroquine Exporters from India — Ranked by Export Value. 163 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Hydroxychloroquine exporters

Certification and compliance status for top Hydroxychloroquine suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
Zydus Lifesciences Limited	Approved	Yes	Yes	89	Received FDA approval for enzalutamide tablets in October 2024.
Intas Pharmaceuticals Limited	Approved	Yes	Yes	89	Acquired Teva's UK and Ireland assets in 2016.
Cadila Pharmaceuticals Limited	Approved	Yes	Yes	Not verified	Received FDA warning in 2014 for manufacturing practices.
Sun Pharmaceutical Industries Limited	Approved	Yes	Yes	89	Received FDA warning in 2020 for Halol facility.
IPCA Laboratories Limited	Warning Letter, July 2015	Yes	Yes	Not verified	Received FDA warning in 2015 for Ratlam facility.
Amneal Pharmaceuticals Private Limited	Approved	Yes	Yes	89	No FDA warning letters issued.
Indoco Remedies Limited	Approved	Yes	Yes	Not verified	Received FDA warning in 2019 for Goa facility.
Wallace Pharmaceuticals Private Limited	Approved	Yes	Yes	Not verified	No FDA warning letters issued.

TransData Nexus reviewed the regulatory standing of 8 leading Hydroxychloroquine exporters from India. 7 hold US FDA facility approvals, 8 maintain WHO-GMP certification, and 8 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Hydroxychloroquine sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," is a pivotal hub for the production of Active Pharmaceutical Ingredients (APIs). The city's pharmaceutical ecosystem is characterized by a concentration of API manufacturers, including companies like Granules India, which specializes in APIs and pharmaceutical formulation intermediates. This robust infrastructure positions Hyderabad as a key player in the supply chain for drugs like hydroxychloroquine, ensuring a steady production of essential APIs.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Major companies such as Zydus Lifesciences Limited (formerly Cadila Healthcare Limited) and Alembic Pharmaceuticals are headquartered here. Zydus Lifesciences, for instance, has been a significant contributor to hydroxychloroquine exports, accounting for 82.5% of total exports valued at $116.8 million between 2022 and 2026. The region's emphasis on formulations complements the API production in Hyderabad, facilitating a seamless transition from raw materials to finished products.

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Hydroxychloroquine exporters from India

March 2025

Acquisition

Zydus Lifesciences Limited — Zydus Lifesciences acquires majority stake in Amplitude Surgical

In March 2025, Zydus Lifesciences entered into exclusive negotiations to acquire an 85.6% stake in France-based Amplitude Surgical SA, a leading medical technology company specializing in lower-limb orthopedic solutions. - IMPACT: This acquisition is expected to diversify Zydus's portfolio, potentially affecting resource allocation for hydroxychloroquine production.

Impact: This acquisition is expected to diversify Zydus's portfolio, potentially affecting resource allocation for hydroxychloroquine production.

November 2025

Fundraising

Zydus Lifesciences Limited — Zydus Lifesciences plans Rs 5,000-crore QIP for debt reduction and M&A

In November 2025, Zydus Lifesciences appointed three investment banks to advise on a qualified institutional placement (QIP) of up to Rs 5,000 crore, aiming to reduce debt and pursue mergers and acquisitions, particularly in the US specialty business. - IMPACT: The capital raised may enhance Zydus's capacity for strategic investments, potentially influencing hydroxychloroquine production capabilities.

Impact: The capital raised may enhance Zydus's capacity for strategic investments, potentially influencing hydroxychloroquine production capabilities.

Common Questions — Hydroxychloroquine Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which hydroxychloroquine supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, ZYDUS LIFESCIENCES LIMITED leads with 259 recorded shipments worth $116.8M. IPCA LABORATORIES LIMITED (146 shipments) and CADILA HEALTHCARE LIMITED (40 shipments) are also established high-volume exporters.

Q How many hydroxychloroquine manufacturers are there in India?

India has 163 active hydroxychloroquine exporters with a combined export market of $141.5M across 3,717 shipments to 86 countries. The top 5 suppliers hold 96.7% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for hydroxychloroquine from India?

Average FOB unit price: $3.62 per unit, ranging from $0.01 to $3581.74. Average shipment value: .

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Hydroxychloroquine

Hydroxychloroquine

Who Exports Hydroxychloroquine from India — 163 Suppliers Behind a $141.5M Market

Top Hydroxychloroquine Exporters from India — Ranked by Export Value

Top Hydroxychloroquine Exporters from India

Related Analysis

Need Details?

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Zydus Lifesciences Limited — Zydus Lifesciences acquires majority stake in Amplitude Surgical

Zydus Lifesciences Limited — Zydus Lifesciences plans Rs 5,000-crore QIP for debt reduction and M&A

Common Questions — Hydroxychloroquine Suppliers from India

Q Which hydroxychloroquine supplier from India is the most reliable for bulk orders?

Q How many hydroxychloroquine manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for hydroxychloroquine from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Zydus Lifesciences Limited — Zydus Lifesciences acquires Agenus's CDMO business

Analysis Methodology